Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cefmetazole Monosodium Salt
2. Cefmetazole Sodium
3. Cefmetazon
4. Cs 1170
5. Cs-1170
6. Cs1170
7. Monosodium Salt, Cefmetazole
8. Salt, Cefmetazole Monosodium
9. Sodium, Cefmetazole
10. U 72791a
11. U-72791a
12. U72791a
13. Zefazone
1. 56796-20-4
2. Cefmetazolo
3. Cefmetazolum
4. Cefmetazolum [inn-latin]
5. Cefmetazolo [inn-spanish]
6. (6r,7s)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
7. Chebi:3489
8. U-72791
9. 3j962ujt8h
10. (6r,7s)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
11. (6r,7s)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
12. 56796-20-4 (free)
13. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-cis)-
14. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-, (6r,7s)-
15. Cs 1170
16. Skf 83088
17. U 72791
18. Cefmetazole (usp/inn)
19. Einecs 260-384-2
20. Brn 0634647
21. Unii-3j962ujt8h
22. Cefmetazole [usan:usp:inn]
23. Cefmetazolesodium
24. Cefmetazole [mi]
25. Prestwick0_000700
26. Prestwick1_000700
27. Prestwick2_000700
28. Prestwick3_000700
29. Cefmetazole [inn]
30. Cefmetazole [usan]
31. Epitope Id:116204
32. Cefmetazole [vandf]
33. Cefmetazole [mart.]
34. Lopac0_000266
35. Bspbio_000859
36. Cefmetazole [usp-rs]
37. Cefmetazole [who-dd]
38. Schembl147832
39. Spbio_002780
40. Bpbio1_000945
41. Cefmetazole Sodium [jan]
42. Chembl1201195
43. Dtxsid7022756
44. Gtpl12215
45. Cefmetazole [usp Impurity]
46. Cefmetazole [usp Monograph]
47. Bcp11998
48. Hy-b1595
49. Zinc3830417
50. Bdbm50350471
51. Mfcd00865068
52. Akos015896219
53. Db00274
54. Sdccgsbi-0050254.p002
55. (6r,7s)-7-({[(cyanomethyl)thio]acetyl}amino)-7-(methyloxy)-3-{[(1-methyl-1h-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
56. (6r,7s)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, Sodium Salt
57. Ac-13154
58. Bs-42476
59. 2,6-difluoro-4-methoxyacetophenone
60. Cs-0013513
61. C08103
62. D00910
63. A831178
64. J-700159
65. Q5057238
66. (6r,7s)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia
67. (6r,7s)-7-(2-(cyanomethylthio)acetamido)-7-methoxy-3-((1-methyl-1h-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
68. (6r,7s)-7-[[2-(cyanomethylthio)-1-oxoethyl]amino]-7-methoxy-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
69. (6r,7s)-7-[2-(cyanomethylsulfanyl)ethanoylamino]-7-methoxy-3-[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanylmethyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
70. (6r,7s)-7-{2-[(cyanomethyl)sulfanyl]acetamido}-7-methoxy-3-{[(1-methyl-1h-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
71. 7beta-{[(cyanomethyl)sulfanyl]acetamido}-7alpha-methoxy-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylic Acid
Molecular Weight | 471.5 g/mol |
---|---|
Molecular Formula | C15H17N7O5S3 |
XLogP3 | -0.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 9 |
Exact Mass | 471.04533019 g/mol |
Monoisotopic Mass | 471.04533019 g/mol |
Topological Polar Surface Area | 239 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 818 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of infections caused by susceptible organisms.
Cefmetazole is a second-generation cephalosporin. The cephalosporins are bactericidal drugs with both gram-positive and gram-negative activity. They inhibit bacterial cell wall synthesis in a way similar to the penicillins. Cefmetazole is more active than 1st-generation cephalosporins against indole-positive Proteus, Serratia, anaerobic gram-negative bacilli (including B. fragilis), and some E. coli, Klebsiella, and P. mirabilis, but is less active than cefoxitin or cefotetan against most gram-negative bacilli.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DC - Second-generation cephalosporins
J01DC09 - Cefmetazole
Absorption
Bioavailability is approximately 100% following intramuscular injection.
No appreciable metabolism.
1.50 ±0.14 hours
The bactericidal activity of cefmetazole results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9887
Submission : 1982-09-03
Status : Inactive
Type : II
Registration Number : 305MF10064
Registrant's Address : No. 1688 Shixian Road, Jining City, Shandong Province
Initial Date of Registration : 2023-05-17
Latest Date of Registration : 2023-05-17
Registration Number : 231MF10089
Registrant's Address : No. 1688 Shixian Road, Jining City, Shandong Province
Initial Date of Registration : 2019-04-11
Latest Date of Registration : 2019-04-11
Registration Number : 229MF10137
Registrant's Address : No. 6, Gaogang Avenue, Jiangyin Industrial Estate, Fuqing, Fuzhou, Fujian, China
Initial Date of Registration : 2017-07-24
Latest Date of Registration : 2017-07-24
Registration Number : 227MF10099
Registrant's Address : No. 1688 Shixian Road, Jining City, Shandong Province
Initial Date of Registration : 2015-04-09
Latest Date of Registration : 2015-04-09
Regulatory Info :
Registration Country : Italy
Brand Name : Metafar
Dosage Form : Cephmetazol 1.000Mg 4Ml 1 Units Parenteral Use
Dosage Strength : 1 vial IM 1 g + 1 ampoule solv 4 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Metafar
Dosage Form : Cephmetazol 1.000Mg 4Ml 1 Units Parenteral Use
Dosage Strength : 1 vial IM 1 g + 1 ampoule solv 4 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Global Sales Information
Market Place
Reply
10 Aug 2018
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Cefmetazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefmetazole, including repackagers and relabelers. The FDA regulates Cefmetazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefmetazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cefmetazole supplier is an individual or a company that provides Cefmetazole active pharmaceutical ingredient (API) or Cefmetazole finished formulations upon request. The Cefmetazole suppliers may include Cefmetazole API manufacturers, exporters, distributors and traders.
click here to find a list of Cefmetazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cefmetazole DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefmetazole active pharmaceutical ingredient (API) in detail. Different forms of Cefmetazole DMFs exist exist since differing nations have different regulations, such as Cefmetazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefmetazole DMF submitted to regulatory agencies in the US is known as a USDMF. Cefmetazole USDMF includes data on Cefmetazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefmetazole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefmetazole suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cefmetazole Drug Master File in Japan (Cefmetazole JDMF) empowers Cefmetazole API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cefmetazole JDMF during the approval evaluation for pharmaceutical products. At the time of Cefmetazole JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cefmetazole suppliers with JDMF on PharmaCompass.
Cefmetazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefmetazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefmetazole GMP manufacturer or Cefmetazole GMP API supplier for your needs.
A Cefmetazole CoA (Certificate of Analysis) is a formal document that attests to Cefmetazole's compliance with Cefmetazole specifications and serves as a tool for batch-level quality control.
Cefmetazole CoA mostly includes findings from lab analyses of a specific batch. For each Cefmetazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefmetazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefmetazole EP), Cefmetazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefmetazole USP).
LOOKING FOR A SUPPLIER?